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Abstract 
Objective: Radiosensitisation caused by titanium dioxide nanoparticles (TiO2-NPs) is investigated 
using phantoms (PRESAGE® dosimeters) and in vitro using two types of cell lines, cultured human 
keratinocyte (HaCaT) and prostate cancer (DU145) cells. 
Methods: Anatase TiO2-NPs were synthesised, characterised and functionalised to allow dispersion in 
culture-medium for in vitro studies and halocarbons (PRESAGE® chemical compositions). PRESAGE® 
dosimeters were scanned with spectrophotometer to determine the radiation dose enhancement. 
Clonogenic and cell viability assays were employed to determine cells survival curves from which the 
dose enhancement levels “radiosensitisation” are deduced. 
Results: Comparable levels of radiosensitisation were observed in both phantoms and cells at 
kilovoltage ranges of x-ray energies (slightly higher in vitro). Significant radiosensitisation (~67 %) of 
control was also noted in cells at megavoltage energies (commonly used in radiotherapy), compared to 
negligible levels detected by phantoms. This difference is attributed to biochemical effects, specifically 
the generation of reactive oxygen species (ROS) such as hydroxyl radicals (•OH), which are only 
manifested in aqueous environments of cells and are non-existent in case of phantoms. 
Conclusions: This research shows that TiO2-NPs improve the efficiency of dose delivery, which has 
implications for future radiotherapy treatments. Literature shows that Ti2O3-NPs can be used as 
imaging agents hence with these findings renders these NPs as theranostic agents. 
Key words: Titanium dioxide, Nanoparticles, Reactive oxygen species, Radiosensitisation. 
Introduction 
There have been various advancements in the 
field of radiotherapy resulting in safer and more 
reliable treatments [1]. Most of these developments 
have been technological improvements used to 
confine the beams to the targets and reduce radiation 
damage to the surrounding healthy tissues [2]. 
However, these technological improvements can also 
be combined with an advanced understanding of 
tumour radiobiology to provide the greatest impact 
on treatment regimens [3, 4]. Thus, improving the 
efficiency of radiotherapy treatments requires a 
combination of these complementary approaches, 
such as the use of radiosensitisation agents [4].  
Tumour radiosensitivity can be modified by 
agents, which enhance the radiation effects in the 
tumour, with the objective of delivering efficient 
radiation doses that can eradicate cancer cells without 
exceeding normal tissue tolerances [5]. In many cases 
the radiosensitising agents can selectively target 
tumour cells [4]. Currently, some radiosensitising 
agents, such as fluorouracil are used clinically 
particularly in adjuvant radiotherapy treatments [4]. 
Early investigations used high atomic number 
(Z) materials [4], such as gold with the aim of 
increasing the cross-sectional radiation interaction 
and production of free radicals, which enhances 
radiation dose through extra photoelectron 
production [6-11]. As the increase in cross-sectional 
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interaction is mainly due to the increased 
photoelectric effect’s probability of occurrence (PE), 
but only significantly with low energy X-rays, where 
the probability of PEs are high. However, very few 
investigations have been conducted into the dose 
enhancement effects provided by low Z materials 
which are generally less toxic. 
Studies have shown that upon irradiation, 
anatase TiO2-NPs generate free radicals that facilitate 
the spontaneous generation of reactive oxygen species 
(ROS), which can damage nucleic acids (e.g., DNA) 
[12-15]. Interestingly, this behaviour has not been 
observed with rutile TiO2-NPs [4]. A correlation 
between the TiO2-NP size and ROS activity has been 
noted, whereby an increase in ROS was observed for 
TiO2-NPs of up to 30 nm in diameter and then 
remained constant for larger particle sizes [16]. It has 
also been reported that increasing the mole fraction of 
oxygen atoms by inclusion of Ti-peroxide can also 
improve radiosensitisation efficiency [16]. In all cases, 
these studies were conducted with low energy X-rays, 
which are of very limited use in clinical radiotherapy. 
Others have shown that titanium dioxide and 
titanium nanotubes can penetrate human 
glioblastoma cells in vitro and stay in the cytosol for 
over 10 days without inducing cytotoxicity or 
decreasing DNA repair efficiency after irradiation 
with a linear accelerator [4]. In vivo studies using rare 
earth doped TiO2-NPs have demonstrated significant 
tumour volume decreases when irradiated with 200 
kV X-rays [14]. Collectively, all these investigations 
used UV radiation, gamma radiation and/or low 
energy X-ray beams. 
In this study, we demonstrate the potential of 
TiO2-NPs for the enhancement of clinically relevant 
megavoltage (MV) radiotherapy beams. Anatase 
TiO2-NPs with an average diameter of 30 nm were 
prepared and studied in vitro using cell culture and 
phantoms. TiO2-NPs proved to be cytocompatible to 
cells, even at very high concentrations. However, 
concurrent megavoltage irradiation resulted in 
significant radiosensitisation of the cells, which is 
proposed to result from the generation of free radicals 
and increased ROS. Specifically, prostate cancer 
(DU145) and keratinocyte (HaCaT) cell lines were 
incubated with TiO2-NP at concentrations ranging 
from 0.5 – 4 mM, and following megavoltage 
irradiation, significant radiosensitisation was 
achieved for both DU145 (14-67%) and HaCaT (9-50%) 
cell lines at 80% cell survival. It should be noted that 
the terms radiosensitisation and dose enhancement 
are used interchangeably throughout this manuscript. 
TiO2-NPs has also been documented to be suitable as 
diagnostic agent through its ability to enhance the 
subject contrast [14], hence this nano-compound 
qualifies to be true theranostic agent. 
Materials and Methods 
Synthesis of Anatase Crystalline Phase 
TiO2-NPs 
Anatase TiO2-NPs were synthesised in 
accordance with a previously published procedure 
[17]. Briefly, sulfuric acid (15 mL, 10% H2SO4) was 
added to Milli Q water (150 mL) and cooled to 0 °C in 
an ice-water bath. TiCl4 (10 mL) was slowly added to 
the solution with vigorous stirring, and after 30 min, 
the mixture was heated to 85 oC for 1 h. The pH was 
adjusted to 7 via the drop-wise addition of 
concentrated ammonia (30%) and the solution was 
cooled to room temperature and allowed to stand for 
12 h. The resulting TiO2-NPs were washed with Milli 
Q water (2 × 15 mL) and isolated via centrifugation 
(5000 rcf, 5 min), followed by drying (80 °C, 500 
mbar). The dried TiO2-NPs were calcinated at 600 °C 
for 2 h to produce a bright white powder.  
Surface Modification of TiO2-NPs 
Two types of TiO2-NPs were prepared with 
different surface modifications. Aminopropyl 
trimethoxysilane (APTS) modified NPs (i.e., amine 
functionalised TiO2-NPs) [18-20] were prepared to 
allow aqueous dispersion for cell studies. 
Poly(ethylene glycol) trimethoxysilane (PEGTS) 
modified NPs (i.e., PEG functionalised TiO2-NPs) [4] 
were prepared to allow dispersion in halocarbons for 
incorporation into PRESAGE® formulations. The 
preparation procedures for these coatings are 
described in the Supplementary information. 
Amine functionalised TiO2-NPs: Bare TiO2-NPs 
(200 mg) were suspended in toluene (10 mL) with 
sonication in a flask complete with a stirrer bar, then 
APTS (200 µL) and butylamine (50 µL) were added. 
The flask was sealed and the mixture was heated at 50 
°C for 2 h with constant stirring. After cooling to room 
temperature, the NPs were isolated via centrifugation 
(2000 rcf, 30 s) and then resuspended in isopropanol 
(40 mL) containing concentrated hydrochloric acid 
(0.2 mL). The NPs were again isolated via 
centrifugation (2500 rcf, 180 s) and then resuspended 
in isopropanol (10 mL). This last washing step was 
repeated once more, and the amine functionalised 
TiO2-NPs were isolated after drying in air for 12 h.  
PEG functionalised TiO2-NPs: Bare TiO2-NPs 
(200 mg) were suspended in toluene (10 mL) with 
sonication in a flask complete with a stirrer bar, then 
PEGTS (200 µL) and butylamine (50 µL) were added. 
The flask was sealed and the mixture was heated at 50 
°C for 6 h with constant stirring. After cooling to room 
temperature, the NPs were isolated via centrifugation 
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(2000 rcf, 30 s) and then resuspended in isopropanol 
(40 mL). The PEG functionalised TiO2-NPs were then 
isolated via centrifugation (2500 rcf, 180 s) and air 
dried for 12 h. 
Characterisation of TiO2-NPs 
Transmission electron microscopy (TEM) was 
performed with a Jeol 1010 microscope (100 KeV) 
equipped with Gatan Orius SC600 CCD-2014 camera, 
and was used to determine NP size distributions. 
TiO2-NP samples were prepared by dispersion in 
ethanol (0.1 mg/mL) with sonication for 180 s, and 
then a drop of the suspension was deposited onto a 
GYCu200 mesh copper holey carbon (25ct) and/or 
GSCu200C-50 strong carbon TEM grids. More than 
100 individual NPs were measured to determine 
average particle diameter. X-ray photoelectron 
Spectrometry (XPS) was performed on a Thermo 
K-alpha X-ray spectrometer, and was used to analyse 
the chemical composition of the NPs. X-ray diffraction 
(XRD) spectroscopy was performed on a Bruker Axs 
D8 ADVANCE spectrometer, and was used to 
determine the crystalline phase of the NPs. 
Thermogravimetric analysis (TGA) was performed on 
a Perkin Elmer Hyphenated Pyris 1 instrument, and 
was used to study the NP coating characteristics. 
Fourier transform infrared (FTIR) spectroscopy was 
performed on a BRUKER TENSOR 27 spectrometer, 
where TiO2-NPs were impregnated in KBr discs and 
was used to study the chemical composition of the NP 
coatings.  
Phantom (PRESAGE® Dosimeter) Fabrication 
The PRESAGE® dosimeters were formulated 
using the following ingredients: polyurethane 
prepolymer (Crystal Clear 200, 48.9 wt% part A and 
44 wt% part B; Smooth-On, Easton, PA, USA), 2 wt% 
leuco dye (leucomalachite green-LMG) as a reporter 
component, 0.1 wt% dibutyltin dilaurate (DBTDL) 
and 5 wt% chloroform (Sigma Aldrich-St Louis, MO) 
was used as a halocarbon radical initiator. PEG 
functionalised TiO2-NPs were homogenously 
dispersed in chloroform with sonication to afford final 
NP concentrations of 0, 0.5, 1 and 4 mM in the 
dosimeters. PRESAGE® dosimeters were fabricated 
according to previously described procedures [4]. The 
final prepared solution was then poured into cuvettes 
which were then placed in a chamber (pressure pot) 
under pressure (ca. 60 psi) for 48 hours for curing. 
This was done in order to eliminate the formation of 
air bubbles inside the dosimeters as a result of 
outgassing [4]. 
Phantom Irradiation 
Irradiation was carried out using both 
kilovoltage (kV) and megavoltage (MV) X-ray beams 
at the Alfred Health Radiation Oncology Department 
(The Alfred Hospital, Melbourne, Australia). For 
kilovoltage energies, the dosimeter were irradiated 
with an 80 kV beam from superficial X-ray therapy 
(SXRT) machine (Therapax 3 Series, Pantak Inc., 
Branford, CT, USA) at radiation doses ranging from 
0-25 Gy. The radiation was delivered as a single 
fraction with a dose rate of 1.090 Gy/min using a 15 
cm diameter collimator with filter 5 and 2.2 mm Al 
HVL. The distance from the X-ray source to the 
surface of cuvettes was fixed at 25 cm. Megavoltage 
irradiation was performed using a 6 MV X-ray beam 
from a medical linear accelerator (LINAC, Clinic 
21EX, Varian Associates Inc., CA, USA). The cuvettes 
were surrounded with solid water (water equivalent 
plastic phantom) to provide a full scatter environment 
with 10 cm2 field size and a 100 cm 
source-surface-distance (SSD). In addition, the 
cuvettes were placed at the centre of the beam to 
ensure all samples received a uniform radiation dose 
and a 5 cm solid water phantom layer was placed on 
top of the cuvettes so that a maximal and uniform 
dose was delivered to the phantoms. A single fraction 
irradiation was delivered to the dosimeter at a 
constant dose rate of 600 MU/min with radiation 
doses ranging from 0-25 Gy. The irradiation setup for 
both kilovoltage and megavoltage X-ray beams is 
shown in Figure 1. 
Optical Density (OD) Measurements 
UV-Vis spectrophotometry was performed on a 
dual-beam Perkin Elmer Lambda 25 UV-VIS 
spectrophotometer (Perkin Elmer, Waltham, MA, 
USA), and was used to measure changes in optical 
density (ΔOD) of the dosimeter cuvettes at an 
absorption maxima of λ = 633 nm [21, 22]. 
Cell Culture 
In this study, human keratinocyte (HaCaT) and 
prostate (DU145) cell lines were used. HaCaT and 
DU145 cells were cultured in RPMI medium 1640 (1X) 
and MEM (Gibco by Life Technologies Pty. Ltd., 
Mulgrave, VIC, Australia) supplemented with 5 % 
and 10 % heat inactivated fetal bovine serum (FBS, In 
Vitro Technology Pty. Ltd., Noble Park, VIC, 
Australia), respectively, and 1 % penicillin 
streptomycin (Gibco by Life Technologies Pty. Ltd., 
Mulgrave, VIC, Australia). Cells were grown in 75 
cm2 flasks (Sigma-Aldrich Pty. Ltd., St Louis, Mo, 
USA) and subcultured at approximately 80 % 
confluency. The cells were incubated in a humidified 
atmosphere at 37 oC, 5% CO2. Cells in passages 4-12 
were used in this research. 
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Figure 1. Illustrations showing setup used for irradiation of phantoms and/or cells in culture: A) kilovoltage irradiation setup and, B) megavoltage irradiation setup. 
Illustrations not to scale. Insets: digital images showing SXRT and LINAC instruments. 
 
For experiments with TiO2-NPs, the dried NP 
power was dispersed in either RPMI medium 1640 
(1X) or MEM for HaCaT and DU145 cells, 
respectively, to provide concentrations ranging from 
1-30 mM. The resulting solutions were filtered 
through a 0.22 μm polysulfonic membranes 
(Sartorius, Goettingen, Germany), sonicated for 30 
min and then used in cell studies. 
TiO2-NPs Association with Cells  
HaCaT cells were seeded in 24-well culture 
plates with a total of 1.5×104 cells per well and 
incubated at 37 °C and 5 % CO2. After 24 h incubation 
the cells were exposed to amine functionalised 
TiO2-NP concentrations of 0.5, 1 and 4 mM for 24 h. 
Subsequently, the culture medium was removed and 
the cells were rinsed with PBS and harvested using 
0.05 % trypsin-EDTA (1X) (Gibco by Life Technologies 
Pty. Ltd., Mulgrave, VIC, Australia). The solution was 
centrifuged at 300 g for 5 min and the cells were 
resuspended in PBS (2 mL). The uptake of TiO2-NPs 
by HaCaT cells was determined by flow cytometry 
(FACS Canto II, BD Biosciences). 10,000 gated events 
were counted and forward and side-scatter were 
recorded. Changes in side-scatter were assessed 
relative to an untreated control cell population. 
Cytotoxicity of TiO2-NPs  
HaCaT and DU145 cells were seeded into 
24-well plates at a density of 3×104 cells per well. Cells 
were then incubated for 24 h at 37 °C and 5 % CO2, 
and then treated with amine functionalised TiO2-NP 
solutions in culture media at concentrations ranging 
from 0-30 mM. A tetrazolium dye-based cell viability 
assay (CellTiter 96® AQueous One Solution Cell 
Proliferation, Promega Corp., Madison, WI, U.S.A.) 
was utilized to assess the cytotoxicity of TiO2-NPs 
[23]. Cytotoxicity was measured at 24, 48 and 72 h 
after TiO2-NP addition. In this preliminary assay, cells 
were not exposed to any radiation. Measurements of 
cell viability were used to determine TiO2-NP 
cytocompatibility.  
Cell Irradiation 
The irradiation methodology for cells followed 
the design/set-up, energies and procedures 
previously detailed in the phantom irradiation 
section. The radiation doses used for cells ranged 
from 0-8 Gy. The irradiation setup is shown in 
Figure 1.  
Cell Survival Assays 
Two methods were implemented for cell survival 
measurements 
MTS survival assay: MTS(3-(4,5-dimethylthiazol- 
2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-
2H-tetrazolium) assays were employed to obtain cell 
survival curves using a CellTiter 96® AQueous One 
Solution Cell Proliferation Assay (Promega Corp., 
Madison, WI, USA). Cells were seeded in 96-well 
plates at a density of 3×103 cells per well and 
incubated at 37 °C, 5 % CO2 for 18 h. The culture 
media was removed, and the cells were treated with 0, 
0.5, 1 and 4 mM of amine functionalised TiO2-NPs 
(200 µL in fresh media) for 24 h. The culture medium 
was changed and the cells were then irradiated with 
kV and MV energies according to the specifications 
previously stated. After irradiation, cells were 
incubated for 24 h, and the media was changed and 
then incubated for a further 48 h. Subsequently, the 
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medium was removed and 300 μL of culture medium 
and 60 μL of CellTiter 96® AQueous One Solution Cell 
Proliferation Assay reagent were added. The assay is 
light sensitive and therefore, cell culture plates were 
wrapped with aluminium foil upon incubation. A 
CLARIOstar microplate reader (BMG LABTECH Inc, 
Ortenberg, Germany) was used for measuring the 
absorbance (optical density) of the solutions at a 
wavelength of 490 nm. The absorbance was recorded 
directly after adding the MTS (for background 
subtraction), and again after 40 min incubation 
period. Measurements are expressed as a percentage 
relative to the negative control cells: 
%100
Background - cells control of Absorbance
Background - cells irradiated of Absorbancefraction  Surviving ×=   
Clonogenic survival assay: After counting, cells 
were seeded in 6-well plates at various densities 
(Table 1) and incubated at 37 °C, 5 % CO2 for 18 h. 
Cells were treated with amine functionalised 
TiO2-NPs and irradiated in an identical procedure to 
that described in the MTS assay. After 14 d 
incubation, the cells were then fixed in (1:7) oleic 
acid/ethanol solution for 5 min and stained with a 0.5 
% crystal violet in ethanol solution for 15 min. The 
plates were then gently washed with water to prevent 
the colonies from loosening and washing off and 
allowed to dry overnight. The colonies were digitally 
scanned using a Leica DMD 108 digital micro-imaging 
instrument (Leica Microsystems CMS GmbH 
manufacture, Mannheim, Germany), and counted 
manually. 
 
Table 1. HaCaT and DU145 cell seeding densities in 6-well plates 
for clonogenic survival assays at specified doses.  
Dose (Gy) Density of seeded cells in 6-well plates (cells/well) 
HaCaT DU145 
0 150 250 
1 250 500 
2 250 750 
3 500 1000 
4 500 1500 
5 750 2000 
6 750 2500 
8 1000 3000 
 
 
In vitro Detection of ROS 
The 2’,7’-Dichlorofluorescin diacetate (DCFDA) 
(Sigma-Aldrich Pty. Ltd., St Louis, Mo, USA) was 
dissolved in dimethyl sulfoxide (DMSO) at a 
concentration of 100 µM, and stored at -20 °C in the 
dark. Immediately before use, the DCFDA solution 
was diluted 1:1000 in PBS (phosphate buffered saline). 
Black 96 well plates were used in this experiment, 
with total solution volumes of 200 µL per well (100 µL 
DCFDA solution). Various concentrations of amine 
functionalised TiO2-NPs (0.5, 1 and 4 mM) were 
prepared in 100 µL PBS. The samples were irradiated 
with 6 MV X-ray beams from an ELECTA LINAC at 
doses of 15 or 40 Gy. The nonfluorescent DCFDA is 
converted to highly fluorescent product 
post-oxidisation in the presence of ROS. The total 
fluorescence of the samples was measured using a 
CLARIOstar microplate reader with excitation and 
emission wavelengths of 483 and 530 nm, 
respectively. All fluorescence measurements were 
performed in the dark and at room temperature. 
Statistical Analysis 
All data represents the mean of three 
independent experiments. Results are reported as 
mean ± SEM. Statistical analysis was performed using 
OriginPro 2016 SR1 v9.3.1.273 software. Two-way 
analysis of variance (ANOVA) was applied to 
determine significance, followed by a Tukey test for 
post-hoc comparisons when significance was 
indicated. Results were considered to be statistically 
significant at p values of less than 0.05 (* p < 0.05, ** p 
< 0.01, *** p < 0.001). 
Results 
Characterisation of Functionalised TiO2-NPs 
TiO2-NPs were synthesised via a chemical 
hydrolysis method as previously reported [17]. TEM 
revealed TiO2-NPs to be spherical with a mean 
diameter of 30 ± 5 nm (Figures 2A and B). X-ray 
diffraction (XRD) patterns of the TiO2-NPs revealed a 
primary peak at 25.3 2 θ (degrees) and numerous 
smaller peaks that confirmed the TiO2 anatase 
structure with a 84.6 % crystal phase (Figure 2C) [17]. 
The elemental composition of the TiO2-NPs was 
determined via X-ray photoelectron spectroscopy 
(XPS), which revealed peaks with characteristic 
binding energies for titanium and oxygen (Figure 2D). 
The additional peak for carbon was used to calibrate 
the relative energies and all peaks are in agreement 
with previous studies [17].  
Subsequently, the bare TiO2-NPs were 
functionalised through silanization with either 
3-aminopropyl trimethoxysilane (APTS) or poly 
(ethylene glycol) propyl trimethoxysilane (PEGTS) to 
afford amino- and PEG-functionalised NPs that could 
be easily dispersed in aqueous and organic solutions, 
respectively (Figure 3). 
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Figure 2. A) TEM image of TiO2-NPs (scale bar 50 nm). B) Size distribution of TiO2-NPs from TEM images. C) XRD. D) XPS spectra of TiO2-NPs.  
 
In comparison with bare TiO2-NPs, TGA analysis 
of the amine- and PEG-functionalised TiO2-NPs 
revealed ~ 5 wt% loss over temperature ranges of 
270-550 °C, which is attributed to the decomposition 
of the organic coating (Figure 4A). Fourier transform 
infrared spectroscopy (FTIR) of the bare and 
functionalised TiO2-NPs showed a typical TiO2 
pattern ranging between 500 ~ 700 cm-1, which is 
attributed to Ti–O–Ti vibrations in the TiO2 lattice 
[17]. The absorption peak at 1639 cm-1 and the broad 
band at 3344 cm-1 in all samples are attributed to the 
surface hydroxyl groups (OH) present in the 
TiO2-NPs (Figure 4B (a, b, c)) [17]. The band at 993 
cm-1 (Ti–O–Si) confirms the condensation reactions 
between the methoxy groups of APTS and the 
TiO2-NPs surface hydroxyl groups has occurred 
(Figure 4B, (c)) [17]. The peak at 1047 cm-1 is due to the 
(Si–O–Si) asymmetric vibrations indicating 
occurrence of condensation reaction with the silanol 
groups (Figure 4B, (c)) [17]. The peaks at ~1130 cm-1 
for the amine and PEG functionalised TiO2-NPs are 
consistent with C–N and C-O vibrations, respectively, 
which demonstrate successful grafting to the surface 
of the modified nanoparticles [17]. Peaks at 1384 cm-1 
and 2931 cm-1 in all samples were attributed to the 
asymmetrical C–H vibrations [17].  
 
Figure 3. Surface modification of TiO2-NPs via silanisation with APTS and 
PEGTS. 
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Figure 4. A) Thermogravimetric curves recorded at a heating rate of 10 °C/min in a nitrogen flow. B) FTIR spectra for bare and surface functionalised TiO2-NPs. 
 
 
Figure 5. Flow cytometry scatter plots of HaCaT cells. A) Without treatment (control), and treated with, B) 0.5, C) 1 and, D) 4 mM TiO2-NP solutions. 
 
TiO2-NPs Association with Cells 
Flow-cytometry (FCM) was used to observe the 
cellular association and/or uptake of NPs by taking 
advantage of the increased visible-light scattering 
caused by TiO2-NPs, relative to the mostly translucent 
cellular environment (Figure 5). HaCaT cells were 
exposed to amine functionalised TiO2-NP 
concentrations of 0.5, 1 and 4 mM for 24 h. Untreated 
cells were used as controls. In treated samples, 
forward scatter (x-axis) remained unchanged 
(suggesting no change in object size), whereas 
side-scatter (y-axis) increased by 945 % (0.5 mM), 1307 
% (1 mM) and 2045 % (4mM) versus the control. This 
suggests a strong association between the cells and 
the NPs in the treated samples, though it does not 
distinguish between NPs within the cells and those 
bound to the cell surface. 
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Cytotoxicity of TiO2-NPs  
HaCaT and DU145 cell lines were exposed to 
amine functionalised TiO2-NPs at concentrations 
ranging from 1 to 8 mM for 24, 48 and 72 h to 
investigate the kinetic tolerance of these cell lines to 
TiO2-NPs. Cell viability was measured via MTS 
assays. Cell viability was expressed as a percentage of 
treated cultures to untreated controls. The results 
indicated that TiO2-NPs were nontoxic up to 4 mM 
post 72 h of treatment (Figure 6A). When cells were 
exposed to higher concentrations (up to 8 mM), 
viability remained constant (100 %) after 24 h (Figure 
6B). 
Dose Enhancement and Radiosensitivity 
Induced by TiO2-NPs 
Low Energy “kV” X-Ray Irradiation 
The radiation enhancement caused by TiO2-NPs 
at kV energy X-rays of the type used in superficial 
X-ray beams was determined by phantom 
(PRESAGE® dosimeter) and in vitro cell based studies. 
PRESAGE® dosimeter can be easily loaded with NPs 
during manufacture, and we have previously used 
this approach [17]. Dose enhancement in PRESAGE® 
dosimeters for the first time loaded with and without 
PEG functionalised TiO2-NPs is obtained by 
measuring the change in optical density (ΔOD) after 
irradiation, using a spectrophotometer. The OD of the 
dosimeter without nanoparticles (control) was 
subtracted from the TiO2-NPs doped dosimeters. The 
dosimeters were irradiated with 80 kV energy X-rays. 
TiO2-NPs concentrations of 0, 0.5 and 1 mM were used 
to investigate NP dose enhancement. It was not 
possible to go beyond a 1 mM concentration of 
TiO2-NPs (or 4 mM TiO2-NPs specifically in the in 
vitro study), as this high concentration caused 
shelding of the incident light passing through the 
PRESAGE® dosimeter, resulting in spectrophotometer 
artifacts during the scanning procedure. The dose 
enhancement factor (DEF) was measured as a ratio 
between the slope of the curve of the TiO2-NPs doped 
dosimeters OD and the slope of the curve of the 
undoped dosimeters OD (control). The average size of 
the NPs (30 nm in diameter) helps to eliminate any 
size effects as previously stated [17]. The ΔOD of the 
dosimeters versus the applied radiation dose is shown 
in Figure 7A. An excellent linear correlation 
coefficient (R2 > 0.99) for the dose response was 
observed for both the control and NP doped 
dosimeters over the applied radiation dose range. 
This linearity indicated that the TiO2-NPs were 
homogeneously dispersed throughout the dosimeter. 
Dose enhancement factors of 1.12 and 1.40 (i.e., an 
increase of 12 and 40 %, respectively) was calculated 
for NP concentrations of 0.5 and 1 mM, respectively 
(Table 2).  
 
Table 2. DEFs for TiO2-NPs in PRESAGE® dosimeter studies and 
in vitro cell studies at 80 % cell survival. 
Energy Study & test type TiO2-NP concentration (mM) 
0.5 mM 1 mM 4 mM 
  
  
 80 kV 
PRESAGE® 1.12 1.40 ------- 
 
HaCaT 
MTS 1.21 1.57 1.70 
Clonogenic 1.17 1.34 1.56 
 
DU145 
MTS 1.27 1.45  1.77  
Clonogenic 1.21 1.40 1.68  
  
  
6 MV 
PRESAGE® 1.04 1.03 ------- 
 
HaCaT 
MTS 1.09 1.19 1.50 
Clonogenic 1.13 1.18 1.37 
 
DU145 
MTS 1.14 1.26 1.67 
Clonogenic 1.10 1.19 1.43 
 
 
 
Figure 6. Cell viability for HaCaT cells exposed to TiO2-NPs. A) Time dependence. B) Concentrations dependence at 24 h. Similar results were observed with 
DU145 cells. 
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Figure 7. Dose enhancement at various concentrations of TiO2-NPs for 80 kV X-ray beam. A) Recorded ΔOD as a function of applied radiation dose for PRESAGE 
dosimeter. B, D) Survival curves for HaCaT cell employing MTS and clonogenic assays, respectively. C, E) Survival curves for DU145 cell lines tested by MTS and 
clonogenic assays, respectively. The errors are standard error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. Results are considered to be statistically significant at p values of less than 0.05 (* p < 0.05, ** p < 0.01, *** p 
< 0.001).  
 
In the in vitro study, HaCaT and DU145 cells 
were utilised to investigate the radiosensitivity effects 
of TiO2-NPs at concentrations of 0.5, 1 and 4 mM. 
Clonogenic and MTS assays were employed for 
determination of the DEF. Data were plotted as log % 
survival fraction vs nominal dose and fitted with a 
linear quadratic model. The survival curves with and 
without TiO2-NPs are displayed in Figures 7B-E, 
which shows the effects of TiO2-NPs concentrations 
for radiation doses of 0-8 Gy at 80 kV on cell survival. 
The DEFs are estimated as a ratio of the control 
survival fraction to the 80 % survival fraction of 
treated cells with TiO2-NPs. The DEFs are 
extrapolated for both cell lines at 80 % survival and 
results indicated survival ranged from 70-77 % for 
MTS assays and 56-68 % for clonogenic assays with a 
TiO2-NPs concentration of 4 mM (Table 2).  
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High Energy “MV” X-Ray Irradiation 
The methods described in the previous section 
(kV X-Ray Irradiation), were repeated to measure the 
radiosensitivity of TiO2-NPs in vitro and in phantom 
with 6 MV X-ray beams. A slight, non-significant dose 
enhancement was detected with the PRESAGE® 
dosimeter (Figure 8A). However, the in vitro study 
(under the same conditions) revealed significant 
radiosensitisation of ~ 50-67 % following the MTS 
assays and 37-43 % from the Clonogenic assays at 
TiO2-NPs concentration of 4 mM (Table 2). The 
survival curves with and without TiO2-NPs are 
displayed in Figures 8B-E. 
 
 
Figure 8. Dose enhancement at various concentrations of TiO2-NPs for 6 MV X-ray beams. A) Recorded ΔOD as a function of applied radiation dose for PRESAGE 
dosimeter. B, D) Survival curves for HaCaT cell employing MTS and clonogenic assays, respectively. C, E) Survival curves for DU145 cells measured by MTS and 
clonogenic assays, respectively. The errors are standard error mean from three independent experiments (mean ± SEM, n=3). The curves are fitted with linear 
quadratic model and DEF was obtained at 80% survival. Results are considered to be statistically significant at p values of less than 0.05 (* p < 0.05, ** p < 0.01, *** p 
< 0.001).  
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Figure 9. ROS generated from TiO2-NPs, detected by DCFDA after exposed 
to 6 MV X-ray beam at radiation doses of (15 and 40) Gy. Results are 
considered to be statistically significant at p values of less than 0.05 (* p < 0.05, 
** p < 0.01, *** p < 0.001). 
 
Generation of ROS by TiO2-NPs  
Figure 9 shows reactive oxygen species (ROS) 
detected after 6 MV beam exposure of aqueous 
solutions without (control) and with TiO2-NPs, as 
measured using 2’,7’-dichlorofluorescin diacetate 
(DCFDA), a fluorogenic dye that measures primarily 
hydroperoxide ROS activity [24]. The use of 
PBS+DMSO solution was to show that there was no 
contribution of these solutions in the ROS generation. 
The results clearly show that ROS generation was 
dependent on TiO2-NPs concentration. This illustrates 
that biochemical effects were a key factor for 
enhancing the cellular radiosensitivity, which would 
be an important consideration in radiosensitivity 
measurements. 
Discussion 
The synthesised TiO2-NPs by the hydrolysis of 
titanium chloride (TiCl4) in sulphuric acid (H2SO4) at 
50 °C is a typical synthesis method for achieving 
uniform nano-crystalline structures with a highly 
pure phase of titania anatase [17]. Data from the 
TiO2-NPs calcined at 600 oC indicated that the anatase 
phase was predominant and no impure phases were 
observed as indicated in the XRD analysis (Figure 2C). 
XPS peaks at 458.9, 464.6, and 530.1-533.4 eV are 
characteristic binding energies of Ti2p3/2, Ti2p1/2 and 
O1s, respectively, which are indicators of the titanium 
and oxygen signals in the TiO2 lattice (Figure 2D). The 
anatase crystal form of TiO2 is preferable as the 
anatase structure creates more free radicals and has a 
larger surface area to volume ratio and therefore 
generates ROS more effectively than other types of 
TiO2-NPs [12-15]. All these features in combination 
have a high impact on DNA damage leading to cells 
death during irradiation.  
TGA analysis of the functionalised TiO2-NPs 
showed that coatings were ~ 6 % of the total NP mass 
(Figure 4A). This indicates that most of the observed 
dose enhancement or radiosensitisation results from 
X-ray interaction with the TiO2-NPs, as the bulk of the 
particle is mainly composed of Ti and oxygen atoms. 
The peaks at 1047 and 1128 cm-1 observed in the FTIR 
spectra demonstrate that the amino and PEG surface 
coatings were successfully grafted on the TiO2-NPs. 
The increased side scatter observed in the flow 
cytometry for TiO2-NPs exposed cells (Figure 5) 
implies close association between the NPs and cells. 
Though this data does not necessary indicate uptake. 
Nevertheless, the NPs will still be in close proximity 
to the nucleus and intracellular uptake may not be an 
absolute necessity for radiation dose enhancement 
[17]. Moreover, the radiation generated free radicals 
and their derivatives can kill the cells by damaging 
other components of the cells which exists in the 
cytoplasm. Other in vitro studies do indicate that 
TiO2-NPs can be internalised by various cell lines [25, 
26], and it has been demonstrated that in the absence 
of cytotoxicity, cells can effectively absorb TiO2-NPs 
to quite high concentrations [27]. The results 
presented here illustrate that the TiO2-NPs were 
cytocompatible up to concentrations of 8 mM; 
therefore, the concentration ranges of NPs used in 
vitro in this study were suitable for studying 
radiosensitasation effects without confounders. 
Conversely, it is not possible to exceed a 1 mM 
concentration with many other NPs compositions 
including gold and bismuth NPs [25, 26]. 
The results of this study confirm that 
radiosensitisation at 80 kV is greater than at 6 MV for 
X-ray energy beams and this supports the work of a 
large number of investigators for other type of NPs 
[27, 28]. The primary difference in the effect of these 
two energies is the domination of the likelihood of 
type of interaction. At low energies (80 kV), the 
dominant process of interaction is the photoelectric 
effect (PE), i.e., absorption of an incident X-ray photon 
completely and ejection of secondary electrons from 
the inner shells of the target atom. While at high 
energies (say 6 MV), the interaction of X-ray photons 
is mainly through Compton scattering which occurs 
at the outer shells of the atom and results into a recoil 
electron and a lower energy photon. Moreover, it is 
well known that the probability for the photoelectric 
effect depends strongly on the atomic number (Z). 
Thus it is anticipated that at 80 kV (where PE is 
dominant), the interaction of X-ray photons with Ti 
atoms in the TiO2-NPs will be much higher than the 
interaction with the tissues. The effective atomic 
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number of TiO2 is 18.49 and that of tissue is about 7.4. 
Therefore, taking the probability of interaction via PE 
to be dependent on Z3, the ratio of the probability of 
PE interaction with TiO2-NPs compared to that with 
tissue will be about 15.6. Even though the 
concentration of Ti is relatively low, this extremely 
high affinity for the PE interaction could cause a 
greatly increased interaction probability and lead to 
the generation of copious secondary electrons hence 
enhancing the radiation effects locally [29]. This extra 
generation of secondary electrons is reflected in the 
results of this study, which indicates clearly in both 
the phantom and in vitro studies that the dose 
enhancements caused by the inclusion of the 
TiO2-NPs were much higher at low energies (80 kV) 
compared to those measured at high energies (6 MV).  
The other point of interest in the results is the 
observed differences in dose enhancement between 
the phantom (dosimeter) and cell culture studies, 
especially at high energies (6 MV). The addition of 
TiO2-NPs slightly increased the physical density of 
the systems, while reducing the density of the free 
electrons – this is due to the TiO2-NPs free electron 
density being about 2.86×1023 e cm-3, whereas in tissue 
it is 3.34×1023 e cm-3. This will result in a slight 
reduction in the density of free electrons when 
TiO2-NPs are present in the target. Thus in absolute 
terms, there is no significant physical dose 
enhancement with the 6 MV beam and this is what the 
PRESAGE® dosimeter study confirmed. The slight 4 % 
dose enhancement detected with the 6 MV beam is 
likely to originate from the PE contribution, as the 
energy spectrum of the MV beam shows some 
residual low energy and PEs, which have been 
previously observed with Au NPs [30].  
There is clearly some disagreement between the 
phantom and in vitro studies in regards to the level of 
radiosensitisation. The cell studies showed higher 
enhancements in radiosensitivity than the phantom 
dosimeters (compared in Figures 7 and 8). This can be 
attributed to the PRESAGE® dosimeters being only 
able to detect electron free radicals directly generated 
(the physical effect) and being not suited to the 
generation of ROS due to a lack of free water 
molecules. Conversely, cells can be affected by a host 
of the biochemical events, such as ROS generation, 
which are additional stresses above those generated 
by secondary electrons (Figure 10), and thus result in 
greater radiosensitivity. This specific point was 
illustrated in this study through three sets of 
experiments measuring ROS levels generated by 
radiation in the presence or absence of TiO2-NPs 
(Figure 9). The common ROS generated by TiO2-NPs 
when exposed to ionizing radiation are superoxide 
(O2–), hydroxyl radical (·OH), hydrogen peroxide 
(H2O2), and singlet oxygen (1O2) [30]. As the 
fluorescence probe (DCFDA) does not discriminate 
between different forms of ROS, it is not possible to 
identify a specific ROS that is responsible for the 
produced oxidative stress observed in these studies. 
The slight variations observed between cells result 
could be due to the difference in their response to the 
radiations and to the inclusion of the TiO2-NPs. 
 
 
 
Figure 10. Schematic diagram showing interaction of X-ray with TiO2-NPs 
result in the production of secondary electrons and ROS through physical and 
biochemical effects.  
 
In conclusion, these results clearly show that 
TiO2-NPs can significantly radio-sensitise cells in 
culture. In particular, the TiO2-NPs are more sensitive 
for the cells than the phantom at MV X-ray beams, 
which are most commonly used in radiotherapy. The 
radiosensitisation caused by the NPs most likely 
results from the generation of ROS that are highly 
effective in cell killing, as opposed to high atomic 
mass effects that are only likely to be prominent at 
kilovoltage energies. The TiO2-NPs were also shown 
to be cytocompatible and therefore larger 
concentrations can potentially be loaded into cells and 
tissues prior to irradiation. The discrepancy between 
the levels of radiosensitisation caused by the same 
concentration of particles as measured in vitro 
compared to phantoms is attributable to ROS 
generation, which is not present in phantoms, but is 
highly detrimental to cells. Further investigations will 
involve expansion of these measurements using other 
radiation beams, particularly the effects of charged 
particles. In addition, testing radiosensitisation 
induced by TiO2-NPs in animal models with potential 
to be applied in future clinical radiotherapy 
applications. Moreover, TiO2 has been documented to 
be potentially a suitable radiologic contrast agent [30], 
hence after proving its value in enhancing the 
radiation effects at the targets through this research 
renders it to be a theranostic agent with dual effects 
simultaneously if it is in radiation targets. 
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